๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside

โœ Scribed by Lisa M. DeAngelis; Willi Kreis; Keith Chan; Ester Dantis; Silvia Akerman


Publisher
Springer
Year
1992
Tongue
English
Weight
534 KB
Volume
29
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Relationship between plasma Ara-C and in
โœ Rustum, Y. M. ;Slocum, H. K. ;Wang, G. ;Bakshi, D. ;Kelly, E. ;Buscaglia, D. ;Wr ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 568 KB

Plasma level Ara-C and Ara-U in vivo and intracellular A r a -0 pools in vivo and in vitro were measured using high-performance liquid chromatography and radioimmunoassay. Plasma Ara-C during High Dose therapy was found in two phases; one, a peak at t% of approximately 5-8 minutes, the other approac

Permanent cerebellar toxicity of cytosin
โœ Joseph H. Friedman; Neetha Shetty ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 840 KB

## Abstract This report provides the first videotape example of a patient with permanent cerebellar ataxia from high dose cytosine arabinoside. This case was unusual in that the patient was young, the effects are seemingly permanent and severe, and corticospinal tract damage also occurred. Early re

Toxicity of high dose Ara-C in children
โœ Nilka J. Barrios; Cameron K. Tebbi; Arnold I. Freeman; Martin L. Brecher ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 517 KB

The toxicity of high dose cytosine arabinoside (Ara-C) in 23 leukemic children aged 1.5 years to 16 years 11 months was evaluated. The group included 11 children with acute lymphoblastic leukemia (ALL), nine with acute nonlymphoblastic leukemia (ANLL), two with chronic myelocytic leukemia (CML) in b

In vitro effect on human leukemic K562 c
โœ Cortesi, R.; Gui, V.; Gambari, R.; Nastruzzi, C. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 479 KB ๐Ÿ‘ 2 views

The administration of retinoids has been demonstrated to be of potential utility in the therapy of a wide spectrum of neoplastic pathologies due to the ability to induce differentiation in a large variety of primary tumor cells as well as in vitro cultured cell lines. Moreover, a number of compounds